Question 1

What EU grants are available for the Biotechnology sector?

Accepted Answer

The European Commission offers a wide range of funding opportunities specifically designed for the Biotechnology sector. These include grants through Horizon Europe (the EU's flagship research and innovation programme with a budget of €95.5 billion), the European Innovation Council (EIC) which provides funding for breakthrough innovations, and various sector-specific initiatives. Funding types range from Research and Innovation Actions (RIA) with 100% funding rates, to Innovation Actions (IA) with 70% funding for companies, and Coordination and Support Actions (CSA) for networking and coordination activities. Our database helps you find grants that match your organization's specific needs, project stage, and funding requirements.

Question 2

How do I apply for Biotechnology grants from the EU?

Accepted Answer

Applying for EU grants in the Biotechnology sector involves several key steps. First, use Grantalist to identify suitable open calls that match your project idea and organization type. Next, carefully review the call documentation, including eligibility criteria, evaluation criteria, and the work programme. Most EU grants require you to form a consortium with partners from at least 3 different EU member states or associated countries. Once ready, you'll submit your proposal through the EU Funding & Tenders Portal, which includes a detailed description of your project, work packages, budget breakdown, and impact assessment. The evaluation process typically takes 3-5 months, after which successful applicants enter grant agreement preparation. We recommend starting your application at least 2-3 months before the deadline.

Question 3

What is the typical funding amount for Biotechnology EU grants?

Accepted Answer

EU grants for the Biotechnology sector offer diverse funding levels depending on the programme and action type. Small-scale grants through programmes like EIC Accelerator can start from €500,000 up to €2.5 million in grant funding, plus up to €15 million in equity investment. Collaborative research projects under Horizon Europe typically range from €3 million to €10 million for standard projects, while some large-scale flagship initiatives can exceed €20 million. SMEs and startups often benefit from higher funding rates (up to 70% for Innovation Actions compared to large companies) and access to specialized instruments. The exact amount depends on the specific call topic, project scope, consortium size, and type of activities proposed.

Question 4

Who is eligible for Biotechnology EU grants?

Accepted Answer

Eligibility for Biotechnology EU grants extends to a wide range of organizations. Legal entities from EU member states and associated countries (including the UK for some programmes, Norway, Switzerland, and others) are typically eligible. This includes universities and research institutions, large enterprises and multinational corporations, small and medium-sized enterprises (SMEs) with fewer than 250 employees, startups and scale-ups, public bodies and NGOs, and international organizations. Some calls specifically target certain organization types, such as SME-only calls or academic-focused research grants. Third-country participation is possible in many programmes, though often without EU funding.

EU Grants for Biotechnology

Enhancing integrated research and healthcare in sub-Saharan Africa through digital innovation and Artificial Intelligence

Training and innovation networks for sustained capacity development related to ethics, regulatory, pharmacovigilance, and related digital regulatory platforms

Space critical EEE components for EU non-dependence – Radiation Hard FPGA on 7nm

Space critical Equipment for EU non-dependence – Space Refuelling Interface

Critical Facilities Serving Space EEE components for EU non-dependence – High and Very High Energy Irradiation Test Facility Market Deployment

Space critical EEE components for EU non-dependence – GaN MMICs mm-Wave Foundations (Phase A): Development and Industrialization of Semi-insulating SiC Substrate Capabilities

Scientific analysis and exploitation of space data

Centres of Vocational Excellence

MSCA Postdoctoral Fellowships 2026

ERA Fellowships

Enhancing the Security, Privacy and Robustness of AI Models and Systems (SecureAI)

Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers

European Partnership on Rare Diseases (ERDERA) (Phase 2)

Producing battery-grade materials for electrodes through sustainable processing and refining of raw materials or developing bio-based materials (BATT4EU Partnership)

Innovative technologies and solutions to improve wind energy systems supporting the Strategic Energy Technology (SET) Plan on wind

Microbiome for early cancer prediction before the onset of disease

Validating policies and business models for affordable and sustainable housing (Built4People Partnership)

Coordinated topic with India on recycling of EV batteries

Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)

Advanced data platforms to integrate whole life carbon in building information tools, assessments, and certification (Built4People Partnership)

Virtual Human Twin (VHT) Models for Cancer Research

R&I in Support of the Clean Industrial Deal: Decarbonisation of energy intensive industries (IA) (Processes4Planet and Clean Steel partnerships)

R&I in Support of the Clean Industrial Deal: Clean Technologies for Climate Action

Approaches and tools for security in software and hardware development and assessment

Advancing recycling technologies for mixed post-consumer textiles waste from blended products

Harnessing the unique properties of marine organisms to deliver sustainable blue bio-based products

Developing managed aquifer recharge techniques (MAR) in a rural context

Understanding biomass flows in Europe

Ensuring continuous effectiveness of protected areas in conserving habitats and species while facing intensifying drivers of biodiversity loss

European mini-slate development

Frequently Asked Questions About Biotechnology EU Grants